{
    "Trade/Device Name(s)": [
        "The Ischemia Albumin Cobalt Binding Test (ACB\u00ae) Assay Verification Set"
    ],
    "Submitter Information": "Inverness Medical Innovations, Inc.",
    "510(k) Number": "K060133",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "January 16, 2006",
    "Summary Letter Received Date": "January 18, 2006",
    "Submission Date": "January 12, 2006",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Ischemia-modified albumin (IMA)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Integra 700",
        "Roche Integra 800"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Verification kit"
    ],
    "Document Summary": "FDA 510(k) summary for the Ischemia Albumin Cobalt Binding Test (ACB\u00ae) Assay Verification Set as a quality control material for verifying ACB Test accuracy on Roche Integra instruments",
    "Indications for Use Summary": "Intended for use in verifying accuracy of the ACB Test on the Roche Integra 700/800 as part of assay installation for in vitro diagnostic use",
    "fda_folder": "Clinical Chemistry"
}